Phase I trial of CNS 102 for amyotrophic lateral sclerosis.
Latest Information Update: 06 Oct 2012
At a glance
- Drugs CNS 102 (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- 06 Oct 2012 New trial record
Latest Information Update: 06 Oct 2012